Document is current
Any future updates will be listed below
-
Authors
van Bokhoven, Pieter https://orcid.org/0000-0002-8218-9921
de Wilde, Arno
Vermunt, Lisa https://orcid.org/0000-0001-7420-6384
Leferink, Prisca S. https://orcid.org/0000-0003-3679-3340
Heetveld, Sasja
Cummings, Jeffrey
Scheltens, Philip https://orcid.org/0000-0002-1046-6408
Vijverberg, Everard G. B.
- License Information
-
More Information
Article History
Received: 4 August 2021
Accepted: 28 October 2021
First Online: 11 November 2021
Declarations
:
: Not applicable.
: Not applicable.
: PvB, PL, SH, and JV declare that they have no competing interests. LV receives administrative support paid to her institution by Olink for CORAL. JV and PvB are advisory consultants for several pharmaceutical companies in the field of neurodegeneration. PS is employed by LSP and Amsterdan University Medical Centers. Dr Scheltens has received consultancy fees (paid to Amsterdam University Medical centers) from AC Immune, Brainstorm Cell, EIP, ImmunoBrain Checkpoint, Genentech, Novartis, Novo Nordisk. He is PI of studies with AC Immune, FUJI-film/Toyama, UCB, and Vivoryon (fees paid to Amsterdam University Medical Center).
